. Concentration of individual (Panel A) and total (Panel B) hepatic ceramides in combined group. NGT -normal glucose tolerance group, IGT -impaired glucose tolerance group; T2D -type 2 diabetes group. Values are mean ± standard deviation; a -p<0.05 vs. NGT, * -p<0.05.
. Correlations between individual hepatic ceramide molecular species and selected anthropometric measurements in combined (both males and females) group.
Values show Pearson's r correlation coefficient together with correlation p-value. Correlations in bold type are significant with p<0.00095 (p value of 0.05 after Bonferroni correction for multiple comparisons); OGTT -oral glucose tolerance test (values for 0min and 120min); HbA1c -glycated hemoglobin; BMI -body mass index; FAT% (DXA) -percentage of body fat as measured by dual-energy X-ray absorptiometry; HOMA-IR -homeostatic model assessment of insulin resistance; a -p<0.00095. C14:0-Cer C16:0-Cer C18:1-Cer C18:0-Cer C20-Cer C22:0- 
